中央研究院 Logo

Schedule

14:00-14:05 Opening Remarks
Dr. Yijuang Chern (Director, Institute of Biomedical Sciences)

I. Immunotherapies
Moderator: Dr. Yu-Ru Lee (Institute of Biomedical Sciences)

14:05-14:25 Dr. Shih-Yu Chen (Institute of Biomedical Sciences)
My Ongoing Journey to Rebuild the Anti-Tumor Immune Cycle

14:25-14:45 Dr. Hsing-Chen Tsai (National Taiwan University Hospital/ Institute of Biomedical Sciences)
The convergence of epigenetic therapy and immunotherapy: shaping tumor–immune dynamics

14:45-15:05 Dr. Chia-Wei Li (Institute of Biomedical Sciences)
Developing novel CAR-T cell therapy for TNBC treatment

15:05-15:30 Coffee Break

II. Precision immunotherapies with frontier drug designs
Moderator: Dr. Yuh-Shan Jou (Institute of Biomedical Sciences/ BioTReC)

15:30-15:50 Dr. Steve Roffler (Institute of Biomedical Sciences)
Glycosidic switch liposomes for cancer therapy

15:50-16:10 Dr. Che-Ming Hu (Institute of Biomedical Sciences/ BioTReC)
Elevating precision onco-immunotherapies through biomaterials engineering

16:10-16:30 Dr. Mi-Hua Tao (Institute of Biomedical Sciences/ BioTReC)
Targeting Tumor Relapse with Neoantigen cancer vaccines: from concept to clinic

16:30-16:50 Dr. Han-Chung Wu (Institute of Cellular and Organismic Biology/ BioTReC)
Discovery and development of therapeutic antibodies for treatment of cancer: From basic research to translational medicine

16:50-17:20 Forum & Closing Remarks